A letter from the UN s Committee on the Elimination of Racism includes allegations Canada failed to take appropriate measures to prevent these acts of violence and to protect the fishers and their properties from being vandalized, and that treaty rights have been breached.
A federal Fisheries Department spokeswoman said in a text Friday that the federal government is reviewing the letter from the UN committee and will respond to the inquiry directly.
Packer, the director of the university s Human Rights Research and Education Centre, said if the group concludes Canada breached terms of a convention that aims to eliminate racism, it harms Canada s credibility, even if the conclusions aren t legally binding.
Canada should engage U N racism group, though chair independence a question: expert | iNFOnews
infotel.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infotel.ca Daily Mail and Mail on Sunday newspapers.
Immobilienexperte: Die Gründe & Folgen des Immobilienbooms in Europa
wiwo.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wiwo.de Daily Mail and Mail on Sunday newspapers.
Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa
News provided by
Share this article
Up to 200,000 Johnson & Johnson
Ebola vaccine regimens will be made available as part of a WHO early access clinical program now underway in Sierra Leone
Company s Ebola vaccine regimen also receives Prequalification from the WHO
The Johnson & Johnson vaccine regimen is designed to be used proactively to induce immunity against Ebola in adults and children
NEW BRUNSWICK, N.J., May 13, 2021 /PRNewswire/ Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and the government of Sierra Leone have begun administering the Company s Ebola vaccine regimen as part of a WHO early access clinical program aimed at preventing further spread of Ebola in West Africa. The vaccine regimen, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) in collaboration with Bavarian Nordic A/S,